A17.89 Other tuberculosis of nervous system

Name of the Condition

• Other tuberculosis of nervous system

Summary

Other tuberculosis of the nervous system refers to tuberculosis (TB) infections affecting the central nervous system (CNS) that do not fall under more specific categories like tuberculous meningitis or tuberculoma. This condition involves Mycobacterium tuberculosis infection in areas such as the brain, spinal cord, or meninges, leading to inflammation and potential neurological complications. Prompt diagnosis and treatment are critical to prevent severe outcomes.

Causes

Other tuberculosis of the nervous system is caused by the spread of Mycobacterium tuberculosis from a primary TB infection, typically in the lungs, to the CNS. The bacteria can reach the nervous system through the bloodstream or by direct extension from adjacent infected tissues. The infection may manifest in various forms, including granulomatous lesions or inflammatory processes, depending on the site and extent of involvement.

Risk Factors

• Active pulmonary tuberculosis or other extrapulmonary TB
• Weakened immune system (e.g., HIV/AIDS, immunosuppressive therapy)
• Malnutrition or chronic illness
• Recent TB exposure or infection
• Lack of access to TB treatment or preventive care

Symptoms

• Persistent headache
• Fever and night sweats
• Neurological deficits (e.g., weakness, numbness, confusion)
• Seizures
• Focal neurological signs (e.g., vision changes, motor impairment)
• Changes in mental status

Diagnosis

Diagnosis involves a combination of clinical evaluation, imaging studies (e.g., MRI or CT scans), and laboratory tests. Cerebrospinal fluid (CSF) analysis may show elevated protein, low glucose, and lymphocytic pleocytosis. Microbiological confirmation, such as acid-fast bacilli staining or nucleic acid amplification tests, is often required. Biopsy of affected tissue may be necessary in some cases.

Treatment Options

Treatment typically includes a multi-drug regimen of antitubercular medications, such as isoniazid, rifampin, pyrazinamide, and ethambutol, administered for an extended period (often 6–12 months). Corticosteroids may be used to reduce inflammation, especially in cases with neurological involvement. Close monitoring for drug resistance and adverse effects is essential.

Prognosis and Follow-Up

Prognosis depends on the extent of CNS involvement, timeliness of treatment, and patient factors (e.g., immune status). Early treatment improves outcomes, but delays can lead to permanent neurological damage. Follow-up includes regular clinical assessments, imaging, and laboratory monitoring to ensure treatment efficacy and detect complications.

Complications

• Permanent neurological deficits (e.g., paralysis, cognitive impairment)
• Hydrocephalus
• Seizure disorders
• Recurrent infection or relapse
• Drug resistance

Lifestyle & Prevention

• Complete the full course of prescribed TB medications to prevent resistance.
• Maintain good nutrition and overall health to support immune function.
• Avoid exposure to individuals with active TB, especially in high-risk settings.
• Follow infection control measures if in contact with TB patients.

When to Seek Professional Help

Seek immediate medical attention if experiencing severe headache, fever, neurological symptoms (e.g., weakness, confusion), or seizures. Early evaluation is critical to prevent irreversible damage.

Tips for Medical Coders

Use code A17.89 for cases of tuberculosis affecting the nervous system that do not fit more specific subcategories (e.g., tuberculoma or meningoencephalitis). Ensure documentation supports the diagnosis, including clinical findings, imaging results, and microbiological confirmation. Verify that the infection is localized to the nervous system and not part of a broader extrapulmonary TB presentation.